Relationship between the gut microbiota and bile acid composition in the ileal mucosa of Crohn's disease.

Crohn disease Mucosa associated microbiota Single-balloon enteroscopy

Journal

Intestinal research
ISSN: 1598-9100
Titre abrégé: Intest Res
Pays: Korea (South)
ID NLM: 101572802

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 30 03 2021
accepted: 12 04 2021
pubmed: 12 5 2021
medline: 12 5 2021
entrez: 11 5 2021
Statut: ppublish

Résumé

Crosstalk between the gut microbiota and bile acid plays an important role in the pathogenesis of gastrointestinal disorders. We investigated the relationship between microbial structure and bile acid metabolism in the ileal mucosa of Crohn's disease (CD). Twelve non-CD controls and 38 CD patients in clinical remission were enrolled. Samples were collected from the distal ileum under balloon-assisted enteroscopy. Bile acid composition was analyzed by liquid chromatography-mass spectrometry. The gut microbiota was analyzed by 16S rRNA gene sequencing. The Shannon evenness index was significantly lower in endoscopically active lesions than in non-CD controls. β-Diversity, evaluated by the UniFrac metric, revealed a significant difference between the active lesions and non-CD controls (P=0.039). The relative abundance of Escherichia was significantly higher and that of Faecalibacterium and Roseburia was significantly lower in CD samples than in non-CD controls. The increased abundance of Escherichia was more prominent in active lesions than in inactive lesions. The proportion of conjugated bile acids was significantly higher in CD patients than in non-CD controls, but there was no difference in the proportion of primary or secondary bile acids. The genera Escherichia and Lactobacillus were positively correlated with the proportion of conjugated bile acids. On the other hand, Roseburia, Intestinibacter, and Faecalibacterium were negatively correlated with the proportion of conjugated bile acids. Mucosa-associated dysbiosis and the alteration of bile acid composition were identified in the ileum of CD patients. These may play a role in the pathophysiology of ileal lesions in CD patients.

Sections du résumé

BACKGROUND/AIMS OBJECTIVE
Crosstalk between the gut microbiota and bile acid plays an important role in the pathogenesis of gastrointestinal disorders. We investigated the relationship between microbial structure and bile acid metabolism in the ileal mucosa of Crohn's disease (CD).
METHODS METHODS
Twelve non-CD controls and 38 CD patients in clinical remission were enrolled. Samples were collected from the distal ileum under balloon-assisted enteroscopy. Bile acid composition was analyzed by liquid chromatography-mass spectrometry. The gut microbiota was analyzed by 16S rRNA gene sequencing.
RESULTS RESULTS
The Shannon evenness index was significantly lower in endoscopically active lesions than in non-CD controls. β-Diversity, evaluated by the UniFrac metric, revealed a significant difference between the active lesions and non-CD controls (P=0.039). The relative abundance of Escherichia was significantly higher and that of Faecalibacterium and Roseburia was significantly lower in CD samples than in non-CD controls. The increased abundance of Escherichia was more prominent in active lesions than in inactive lesions. The proportion of conjugated bile acids was significantly higher in CD patients than in non-CD controls, but there was no difference in the proportion of primary or secondary bile acids. The genera Escherichia and Lactobacillus were positively correlated with the proportion of conjugated bile acids. On the other hand, Roseburia, Intestinibacter, and Faecalibacterium were negatively correlated with the proportion of conjugated bile acids.
CONCLUSIONS CONCLUSIONS
Mucosa-associated dysbiosis and the alteration of bile acid composition were identified in the ileum of CD patients. These may play a role in the pathophysiology of ileal lesions in CD patients.

Identifiants

pubmed: 33975420
pii: ir.2021.00054
doi: 10.5217/ir.2021.00054
pmc: PMC9344239
doi:

Types de publication

Journal Article

Langues

eng

Pagination

370-380

Subventions

Organisme : Japan Agency for Medical Research and Development
ID : JP20gm1010008h9904
Organisme : Japan Agency for Medical Research and Development
ID : 20ek0410056
Organisme : Ministry of Health, Labour and Welfare
ID : 20FC1037
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 18K10990
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 18K08002

Références

Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):205-17
pubmed: 25732745
Appl Environ Microbiol. 2009 Dec;75(23):7537-41
pubmed: 19801464
FEMS Microbiol Rev. 2005 Sep;29(4):625-51
pubmed: 16102595
Curr Opin Microbiol. 2017 Oct;39:1-6
pubmed: 28783509
Gastroenterology. 2017 Feb;152(2):313-321.e2
pubmed: 27793607
Nat Rev Gastroenterol Hepatol. 2018 Feb;15(2):111-128
pubmed: 29018272
Inflamm Bowel Dis. 2018 Apr 23;24(5):1035-1044
pubmed: 29688473
Science. 2009 Dec 18;326(5960):1694-7
pubmed: 19892944
Nat Rev Immunol. 2016 Oct;16(10):639-49
pubmed: 27498766
Science. 2018 Nov 30;362(6418):
pubmed: 30498100
Gut. 2013 Apr;62(4):531-9
pubmed: 22993202
Cell Host Microbe. 2020 Apr 8;27(4):659-670.e5
pubmed: 32101703
Gastroenterology. 1976 Mar;70(3):439-44
pubmed: 1248701
Nat Rev Gastroenterol Hepatol. 2020 Apr;17(4):223-237
pubmed: 32076145
Gut Microbes. 2020 Nov 9;12(1):1788898
pubmed: 32691669
Int Immunol. 2014 Sep;26(9):481-7
pubmed: 24792038
Digestion. 2016;93(1):59-65
pubmed: 26789999
J Gastroenterol. 2014 May;49(5):785-98
pubmed: 24652102
J Lipid Res. 1988 Jul;29(7):847-58
pubmed: 3411245
J Gastroenterol. 2015 May;50(5):495-507
pubmed: 25808229
Lancet. 2007 May 12;369(9573):1641-57
pubmed: 17499606
Nature. 2019 May;569(7758):655-662
pubmed: 31142855
Inflamm Bowel Dis. 2012 May;18(5):968-84
pubmed: 21936031
Clin J Gastroenterol. 2018 Feb;11(1):1-10
pubmed: 29285689
Nat Microbiol. 2019 Feb;4(2):293-305
pubmed: 30531976
J Gastroenterol Hepatol. 2020 Mar;35(3):380-389
pubmed: 31596960
Inflamm Bowel Dis. 2011 Jan;17(1):179-84
pubmed: 20839241
J Gastroenterol. 2018 Jan;53(1):95-106
pubmed: 28852861
Gut Microbes. 2016;7(1):22-39
pubmed: 26939849
Gastroenterology. 2008 Feb;134(2):577-94
pubmed: 18242222

Auteurs

Shigeki Bamba (S)

Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.

Osamu Inatomi (O)

Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.

Atsushi Nishida (A)

Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.

Masashi Ohno (M)

Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.

Takayuki Imai (T)

Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.

Kenichiro Takahashi (K)

Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.

Yuji Naito (Y)

Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Junichi Iwamoto (J)

Department of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.

Akira Honda (A)

Joint Research Center, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.

Naohiro Inohara (N)

Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.

Akira Andoh (A)

Division of Gastroenterology, Shiga University of Medical Science, Otsu, Japan.

Classifications MeSH